Quest Diagnostics Incorporated
DGX

$18.26 B
Marketcap
$163.59
Share price
Country
$-0.30
Change (1 day)
$165.04
Year High
$123.04
Year Low

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

marketcap

P/E ratio for Quest Diagnostics Incorporated (DGX)

P/E ratio as of 2023: 18.08

According to Quest Diagnostics Incorporated's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 18.08. At the end of 2022 the company had a P/E ratio of 19.18.

P/E ratio history for Quest Diagnostics Incorporated from 1996 to 2023

PE ratio at the end of each year

Year P/E ratio
2023 18.08
2022 19.18
2021 10.84
2020 11.16
2019 16.68
2018 15.39
2017 17.48
2016 19.95
2015 14.45
2014 17.49
2013 9.59
2012 16.63
2011 19.58
2010 13.15
2009 15.40
2008 17.34
2007 30.07
2006 17.80
2005 19.02
2004 19.50
2003 17.33
2002 17.04
2001 41.22
2000 62.28
1999 -305.60
1998 19.78
1997 -21.92
1996 -0.71